Trade Mark Journal No.2026/013 27 March 2026

UK00004356382 17 March 2026 (5,10)

NORVIXA

International priority date claimed: 5 February 2026 (European Union Intellectual Property Office (EUIPO)) (019313551)

Class 5: Pharmaceuticals; pharmaceutical and medical preparations.
Class 10: Pharmaceutical and medical devices; pharmaceutical and medical instruments; surgical and medical apparatus and instruments.

Glenmark Pharmaceuticals s.r.o.

Representative: Boult Wade Tennant LLP